The EnVision Summit, co-founded by Bonnie An Henderson, MD, is a unique family-oriented, multispecialty ophthalmology CME conference, along with a newly introduced optometry track. Henderson sits down with Ophthalmology Times to talk about the 2025 conference that will take place February 14 to 17 at the Caribe Hilton San Juan, in Puerto Rico.
This series features experts in ophthalmology sharing their thoughts on the one unsolved challenge they wish there was a solution for.
Answers to common questions that can help kick-start the journey into the metaverse to learn from the many virtual educational meetings and conference opportunities while mingling with colleagues worldwide.
Considerations in the treatment of diabetic retinopathy and diabetic macular edema.
Minimizing clinic visits, maximizing use of imaging modalities are key.
Ophthalmologists end their discussion on the management of dry eye disease with other ocular comorbidities highlighting key takeaways and prospective advances in care and outcomes.
Considerations in the treatment of diabetic retinopathy and diabetic macular edema.
Systemic immunosuppression may prevent devastating complication in patients.
Ophthalmologists can reduce IOP and medications with endocyclophotocoagulation while in the eye.
Procedure can improve best-corrected visual acuity, enhancing quality of life for patients.
The retina is a key proving ground for long-held theories of genetics.
Need to eliminate errors results in optimization of training of novice surgeons.
Carl D. Regillo, MD, and Jennifer I. Lim, MD, emphasize the high regulatory standards of equivalence and safety of biosimilars in considering the role they will play in the evolving treatment landscape for retinal disorders.
Prompt and adequate action is a key to facilitating the best recovery in patients.
Ocuphire Pharma and Viatris developed the drug together for the reversal of pharmacologically-induced mydriasis (RM) produced by adrenergic agonist or parasympatholytic agents.
Working as an investigator can prove to be a positive experience for physicians
Kamran Riaz, MD, reviews a cataract surgery case where the patient was fitted with different IOLs in each eye.
A patient's vision loss leads to another diagnosis
Researchers find a strong link between Alzheimer's disease and retinal thinning
The 18th annual Controversies in Modern Eye Care conference, held on May 4, 2024, in Los Angeles, was co-chaired by Neda Shamie, MD, and Arjan Hura, MD, with the aim of discussing the latest advancements in eye care.
Unlocking the potential of donor scleral tissue: Innovations and future applications.
Dilsher S. Dhoot, MD discusses a recent case-based roundtable meeting on anti-VEGF biosimilars, highlighting the first of two case discussions.
Optometry cochairs Kelly K. Nichols, OD, MPH, PhD, FAAO, and A. Paul Chous, OD, MA, FAAO, highlight the conference’s focus on collaboration, featuring topics like red flags for patient care, thyroid eye disease, and diabetes management.
One obvious trend has been that dry eye disease is a concurrent problem for virtually all my patients, and we need to address it for optimum comfort and surgical results.
Enhanced monofocal technology may benefit patients with cataracts and dry eye.
Treatment of patients with COVID-19 should include ophthalmic considerations.